Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report

• Autori principali: I. Sermet-Gaudelus (Autore), V. Stoven (Autore), J. P. Annereau (Autore), V. Witko-Sarsat (Autore), P. Reinert (Autore), M. Guyot (Autore), B. Descamps-Latscha (Autore), J. Y. Lallemand (Autore), G. Lenoir (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 1999-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Cystic fibrosis (CF) lung disease is characterized by persistent inflammation. Antiinflammatory drugs, such as corticosteroids and ibuprofene, have proved to slow the decline of pulmonary function although their use is limited because of frequent adverse events. We hypothesized that colchicine could...